HCC Archives - British Liver Trust

New drug approved for patients in Scotland with primary liver cancer

The Scottish Medicines Consortium (SMC) has recommended the use of a new medicine, atezolizumab (Tecentriq), for patients …

Read More

British Liver Trust welcomes announcement from NICE that recommends selective internal radiation therapies for treating liver cancer

sirt

The National Institute for Health and Care Excellence (NICE) has today recommended that selective internal radiation therapy …

Read More

Faster diagnosis needed to beat deadliest cancers

sirt

The British Liver Trust is calling for is calling for focus, prioritisation and investment in order to …

Read More
Skip to content